Drug recall · October 2, 2019
Fexofenadine HCl Tablets recall
Why: Failed Impurities/Degradation Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc., Anaheim, CA, NDC #: 68788-6848-09
- Lots / codes
Lot #: G0219K, Exp 3/2021; C1419E, Exp 3/2021
- Quantity
- 79 (90 ct.) bottles
- Company
- Preferred Pharmaceuticals, Inc, Anaheim, CA
- Distribution
- Product was distributed to 1 physician in Gainesville Florida.
- Initiated
- August 29, 2019 · Voluntary: Firm initiated
- Classified
- September 24, 2019
- Reported
- October 2, 2019
- Ended
- April 24, 2023
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fexofenadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.